First In Human Clinical Trial For DMAb Against Zika Approved By FDA
Posted by
www.biotecnika.org
First In Human Clinical Trial For DMAb Against Zika Approved By FDA
The Wistar Institute, together with Penn Medicine & Inovio
Pharmaceuticals Inc., announced that FDA has approved their initiation
of a first-in-human clinical trial for investigating the safety and
tolerability of a novel synthetic DNA-encoded monoclonal antibody
(DMAb) therapeutic technology to prevent Zika virus […]
The post First In Human Clinical Trial For DMAb Against Zika Approved
By FDA appeared first on BioTecNika .
https://www.biotecnika.org/2019/01/first-in-human-clinical-trial-for-dmab-against-zika-approved-by-fda/
Biotech News
Subscribe to:
Post Comments (Atom)
Post a Comment